Manufacturing

Michael Moedler, PhD, is head of Training at Lonza Biologics Operations Visp.

Helene Pora, PhD, is vice-president of Technical Communication and Regulatory Strategy at Pall Corporation.

Articles

Workforce training is crucial for biopharmaceutical manufacturing.

Addressing the Training Gap for Single-Use Technologies

Feliza Mirasol is the science editor for 

The growing demand for antibody and other bio-therapeutics will require long-term scale-up solutions.

Large-Scale Single-Use Bioreactors Can Maximize Long-Term Scale Up

The use of bioengineering offers practical tools for the evolution of host cells.

Outlining Cell Lines’ Future with Engineering Approaches

The growing use of automation and digitalization technologies push cell culture bioprocessing forward.

Cell Culture Processing Continually Advances

Prashant Pokhriyal is associate scientist at Intas Pharmaceuticals Ltd. (Biopharma Division), Ahmedabad, Gujarat, India.

Prateek Gupta is senior general manager at Intas Pharmaceuticals Ltd. (Biopharma Division), Ahmedabad, Gujarat, India.

Sridevi Khambhampaty is vice-president at Intas Pharmaceuticals Ltd. (Biopharma Division), Ahmedabad, Gujarat, India.

Rajesh Ullanat is executive vice-president at Intas Pharmaceuticals Ltd. (Biopharma Division), Ahmedabad, Gujarat, India.

Mili Pathak is principal scientist, Process Science, R&D, at Intas Pharmaceuticals Ltd. (Biopharma Division), Ahmedabad, Gujarat, India.

Modeling techniques can improve process control and monitoring in biopharmaceutical production.

Recent Trends in Data Analytics for Upstream Process Workflows

Upstream processing is better optimized with the help of automated workflows.

Automating Upstream Processes Helps Sync Workflows

FUJIFILM Irvine Scientific’s new manufacturing facility in Tilburg, the Netherlands, is now fully operational.

FUJIFILM Irvine Scientific Opens New European Manufacturing Facility

Sartorius will invest approximately €270 million (US$305 million) to expand its biopharmaceutical manufacturing activities in South Korea’s biopharm hub.

Sartorius Launches Expansion in South Korea with Mullti-Million Dollar Investment

Lonza is expanding its microbial development capabilities at its Visp, Switzerland, site to support clinical and commercial drug development programs.

Lonza Invests in Microbial Development Lab Expansion

The adoption of perfusion cell culture continues to advance with the help of PAT tools.

Manufacturing Equipment, Upstream Processing